[1] Pedroza M, To S, Smith J, et al.Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride[J]. PLoS One, 2019, 14(7): e0218971.
[2] Du W, Wang L.The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis[J]. Front Immunol, 2022, 13: 936196.
[3] Iwakiri Y, Trebicka J.Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy[J]. JHEP Rep, 2021, 3(4): 100316.
[4] Su T, Yang Y, Lai S, et al.Single-Cell Transcriptomics Reveals Zone-Specific Alterations of Liver Sinusoidal Endothelial Cells in Cirrhosis[J]. Cell Mol Gastroenterol Hepatol, 2021, 11(4): 1139-1161.
[5] Duan T, Du Y, Xing C, et al.Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity[J]. Front Immunol, 2022, 13: 812774.
[6] Liu ZN, Wu X, Fang Q, et al.CD73 Attenuates Alcohol-Induced Liver Injury and Inflammation via Blocking TLR4/MyD88/NF-κB Signaling Pathway[J]. J Inflamm Res, 2022, 15: 53-70.
[7] Dong G, Huang X, Wu L, et al.SREBF2 triggers endoplasmic reticulum stress and Bax dysregulation to promote lipopolysaccharide-induced endothelial cell injury[J]. Cell Biol Toxicol, 2022, 38(1): 185-201.
[8] Zhang Y, Zhu X, Zheng D, et al.Effects of Qutan Huoxue Formula on the SOCS1/TLR4 Signaling Pathway in NASH Model Mice[J]. Evid Based Complement Alternat Med, 2020, 2020: 1570918.
[9] Hu N, Guo C, Dai X, et al.Forsythiae fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways[J]. J Ethnopharmacol, 2020, 262(15): 113275.
[10] Wang F, Li Z, Chen L, et al.Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis[J]. Acta Pharm Sin B, 2022, 12(9): 3618-3638.
[11] Lin YT, CHen LK, Jian DY, et al.Visfatin Promotes Monocyte Adhesion by Upregulating ICAM-1 and VCAM-1 Expression in Endothelial Cells via Activation of p38-PI3K-Akt Signaling and Subsequent ROS Production and IKK/NF-κB Activation[J]. Cell Physiol Biochem, 2019, 52(6): 1398-1411.
[12] Shen X, Zhao J, Wang Q, et al.The Invasive Potential of Hepatoma Cells Induced by Radiotherapy is Related to the Activation of Hepatic Stellate Cells and Could be Inhibited by EGCG Through the TLR4 Signaling Pathway[J]. Radiat Res, 2022, 197(4): 365-375.
[13] Dirscherl K, Schläpfer M, Z'graggen BR, et al. Hypoxia sensing by hepatic stellate cells leads to VEGF-dependent angiogenesis and may contribute to accelerated liver regeneration[J]. Sci Rep, 2020, 10(1): 4392.
[14] Ruan W, Zhao F, Zhao S, et al.Knockdown of long noncoding RNA MEG3 impairs VEGF-stimulated endothelial sprouting angiogenesis via modulating VEGFR2 expression in human umbilical vein endothelial cells[J]. Gene, 2018, 649: 32-39.
[15] Lee AR, Baek SM, Lee SW, et al.Nuclear VEGFR-2 Expression of Hepatocytes Is Involved in Hepatocyte Proliferation and Liver Regeneration During Chronic Liver Injury[J]. In Vivo, 2021, 35(3): 1473-1483.
[16] Lorenz L, Axnick J, Buschmann T, et al.Mechanosensing by β1 integrin induces angiocrine signals for liver growth and survival[J]. Nature, 2018, 562(7725): 128-132.
[17] Lao Y, Li Y, Zhang P, et al.Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to Bypass Fibrosis during Chronic Liver Injury in Mice[J]. Mol Ther, 2018, 26(12): 2779-2797.
[18] Jin J, Yang H, Hu L, et al.Inonotsuoxide B suppresses hepatic stellate cell activation and proliferation via the PI3K/AKT and ERK1/2 pathway[J]. Exp Ther Med, 2022, 23(6): 417.
[19] Tai Y, Zhao C, Zhang L, et al.Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress[J]. J Cell Mol Med, 2021, 25(22): 10389-10402.
[20] Chen T, Shi Z, Zhao Y, et al.LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway[J]. BMC Med, 2022, 20(1): 335.
[21] Duan JL, Ruan B, Yan XC, et al.Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice[J]. Hepatology, 2018, 68(2): 677-690.
[22] Wild SL, Elghajiji A, Rodriguez CG, et al.The Canonical Wnt Pathway as a Key Regulator in Liver Development, Differentiation and Homeostatic Renewal[J]. Genes (Basel), 2020, 11(10): 1163.
[23] Kumar S, Duan Q, Wu R, et al.Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis[J]. Adv Drug Deliv Rev, 2021, 176: 113869.
[24] Kumar V, Dong Y, Kumar V, et al.The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis[J]. Theranostics, 2019, 9(25): 7537-7555.
[25] Tong G, Chen X, Lee J, et al.Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway[J]. Pharmacol Res, 2022, 178: 106139.
[26] Fang C, Pan J, Qu N, et al.The AMPK pathway in fatty liver disease[J]. Front Physiol, 2022, 13: 970292.
[27] Tang N, Hong F, Hao W, et al.Riboflavin ameliorates mitochondrial dysfunction via the AMPK/PGC1α/HO1 signaling pathway and attenuates carbon tetrachlorideinduced liver fibrosis in rats[J]. Exp Ther Med, 2022, 24(4): 608.
[28] Xu L, Li H, Zhang O, et al.Melatonin alleviates diet-induced steatohepatitis by targeting multiple cell types in the liver to suppress inflammation and fibrosis[J]. J Mol Endocrinol, 2022, 70(1): e220075.
[29] Ma Y, Ding Q, Qian Q, et al.AMPK-Regulated Autophagy Contributes to Ursolic Acid Supplementation-Alleviated Hepatic Steatosis and Liver Injury in Chronic Alcohol-Fed Mice[J]. ACS Omega, 2022, 8(1): 907-914.
[30] Hu L, Su L, Dong Z, et al.AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model[J]. J Mol Med (Berl), 2019, 97(3): 423-434.
[31] Van Loy T, De Jonghe S, Castermans K, et al.Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model[J]. Cell Mol Life Sci, 2022, 79(6): 293.
[32] Kandikattu HK, Venkateshaiah SU, Mishra A.Chronic Pancreatitis and the Development of Pancreatic Cancer[J]. Endocr Metab Immune Disord Drug Targets, 2020, 20(8): 1182-1210.
[33] Griffiths K, Habiel DM, Jaffar J, et al.Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis[J]. Sci Rep, 2018, 8(1): 3212.
[34] Qin L, Qin J, Zhen X, et al.Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis:A study in vitro and in vivo[J]. Biomed Pharmacother, 2018, 101: 599-607.
[35] Zhang P, Yue K, Liu X, et al.Endothelial Notch activation promotes neutrophil transmigration via downregulating endomucin to aggravate hepatic ischemia/reperfusion injury[J]. Sci China Life Sci, 2020, 63(3): 375-387.
[36] Shen H, Yu H, Li QY, et al.Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells[J]. Acta Pharmacol Sin, 2022, 43(11): 2917-2928.
[37] Hilscher MB, Sehrawat T, Arab JP, et al.Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension[J]. Gastroenterology, 2019, 157(1): 193-209.
[38] Guo Q, Furuta K, Islam S, et al.Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis[J]. Front Immunol, 2022, 13: 983255.
[39] Peng Z, Pang H, Wu H, et al.CCL2 promotes proliferation, migration and angiogenesis through the MAPK/ERK1/2/MMP9, PI3K/AKT, Wnt/βcatenin signaling pathways in HUVECs[J]. Exp Ther Med, 2022, 25(2): 77.
[40] Wang Z, Shi X, Zhao Y, et al.DC101, an anti-VEGFR2 agent, promotes high-endothelial venule formation and immune infiltration versus SAR131675 and fruquintinib[J]. Biochem Biophys Res Commun, 2023, 661: 10-20.
[41] Nishimichi N, Tsujino K, Kanno K, et al.Induced hepatic stellate cell integrin, α8β1, enhances cellular contractility and TGFβ activity in liver fibrosis[J]. J Pathol, 2021, 253(4): 366-373.
[42] Huang T, Li YQ, Zhou MY, et al.Focal adhesion kinase-related non-kinase ameliorates liver fibrosis by inhibiting aerobic glycolysis via the FAK/Ras/c-myc/ENO1 pathway[J]. World J Gastroenterol, 2022, 28(1): 123-139. |
